inhibits TGF-β and activin signaling by suppressing Smad3 phosphorylation without affecting the MAPK/p38
FGF- and EGF-induced endothelial cord Formation with EC50 of 47
and transcriptomics and phosphoproteomics profiling of acute degradation of CDK6 enabled dynamic mapping of its immediate role in coordinating signaling and transcription
Nepafenac significantly inhibits the number of transferase-mediated dUTP nick-end labeling-positive capillary cells
5-20 mg/kg once or twice per day to inhibit tumor growth
CRBN-6-5-5-VHL cephalosporanic acid inhibits TGF-β and activin signaling(2S, 4R) 1 ((2S) 2 (5 ((5 ((6 ((2 (2, 6 Dioxopiperidin 3 yl) 1, 3 dioxoisoindolin 4 yl)amino)hexyl)oxy)pentyl)oxy)pentanamido) 3, 3 dimethylbutanoyl) 4 hydroxy N (4 (4 methylthiazol 5 yl)benzyl)pyrrolidine 2 carboxamide Product information CAS Number: 2362575 45 7 Molecular Weight: 972. 20 Formula: C51H69N7O10S Chemical Name: (2S, 4R) 1 ((2S) 2 (5 ((5 ((6 ((2 (2, 6 Dioxopiperidin 3 yl) 1, 3 dioxoisoindolin 4 yl)amino)hexyl)oxy)pentyl)oxy)pentanamido)